Skip to main content
Log in

Template-based alignment modeling: an innovative ligand-based approach for medicinal chemists

  • Review Article
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

A single protein-binding pocket often times binds to a diverse range of ligands with distinct structural features. Understanding the structural correlations of the different ligands remains a major challenge in medicinal chemistry research. We recently developed the template-based alignment modeling (TAM) method as a simple yet effective approach for understanding structure–activity relationships (SARs) for a variety of medicinal agents. In this article, we briefly review the developmental process of TAM, and then showcase some potential applications. Finally, within the conceptual framework of TAM, we discuss our view of the structural correlation issue of diverse ligands.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  • Anna Maria P (2018) From morphine to endogenous opioid peptides, e.g., endorphins: the endless quest for the perfect painkiller. Substantia 2(2):81–91

    Google Scholar 

  • Aubry A, Birlirakk N, Sakarellos-Daitsiotis M, Sakarellos C, Marraud M (1988) Relationship of the crystal and molecular structure of leucine-enkephalin trihydrate to that of morphine. J Chem Soc Chem Commun 1988:963–964

    Article  Google Scholar 

  • Chang C, Ekins S, Bahadduri P, Swaan PW (2006) Pharmacophore-based discovery of ligands for drug transporters. Adv Drug Deliv Rev 58:1431–1450

    Article  CAS  Google Scholar 

  • Compton DR, Gold LH, Ward SJ, Balster RL, Martin BR (1992) Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J Phafmacol Exp Ther 263:1118–1126

    CAS  Google Scholar 

  • Eguchi M, Shen RY, Shea JP, Lee MS, Kahn M (2002) Design, synthesis, and evaluation of opioid analogues with non-peptidic beta-turn scaffold: enkephalin and endomorphin mimetics. J Med Chem 45:1395–1398

    Article  CAS  Google Scholar 

  • Harland AA, Bender AM, Griggs NW, Gao C, Anand JP, Pogozheva ID, Traynor JR, Jutkiewicz EM, Mosberg HI (2016) Effects of N-substitutions on the tetrahydroquinoline (THQ) core of mixed-efficacy mu-opioid receptor (MOR)/delta-opioid receptor (DOR) ligands. J Med Chem 59:4985–4998

    Article  CAS  Google Scholar 

  • Hua T, Vemuri K, Nikas SP, Laprairie RB, Wu Y, Qu L, Pu M, Korde A, Jiang S, Ho JH, Han GW, Ding K, Li X, Liu H, Hanson MA, Zhao S, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ (2017) Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature 2017:468–471

    Article  Google Scholar 

  • Montanari F, Ecker GF (2015) Prediction of drug-ABC-transporter interaction—recent advances and future challenges. Adv Drug Deliv Rev 86:17–26

    Article  CAS  Google Scholar 

  • Naaz F, Haider MR, Shafi S, Yar MS (2019) Anti-tubulin agents of natural origin: targeting taxol, vinca, and colchicine binding domains. Eur J Med Chem 171:310–331

    Article  CAS  Google Scholar 

  • Pascual R, Almansa C, Plata-Salaman C, Vela JM (2019) A new pharmacophore model for the design of sigma-1 ligands validated on a large experimental dataset. Front Pharm 10:519

    Article  CAS  Google Scholar 

  • Pradeep H, Rajanikant GK (2012) A rational approach to selective pharmacophore designing: an innovative strategy for specific recognition of Gsk3β. Mol Divers 16:553–562

    Article  CAS  Google Scholar 

  • Saito T, Hirai H, Kim YJ, Kojima Y, Matsunaga Y, Nishida H, Sakakibara T, Suga O, Sujaku T, Kojima N (2002) CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502. J Antibiot 55:847–854

    Article  CAS  Google Scholar 

  • Wu Z (2013) Construction validation and application of an artificial template for the template-based alignment modeling on the N-terminal inhibitors of Hsp90. 246th ACS national meeting, September 8–12, 2013, Indianapolis, IN

  • Wu Z (2020) Template-based alignment modeling of the structure-activity relationships of CB2R ligands. ACS Spring 2020 National Meeting & Exposition. https://www.morressier.com/article/templatebased-alignment-modeling-structureactivity-relationships-cb2r-ligands/5e7374cfcde2b641284ac24a?

  • Wu Z, Hruby VJ (2011) Backbone alignment modeling of the structure-activity relationships of opioid ligands. J Chem Inf Model 51:1151–1164

    Article  CAS  Google Scholar 

  • Wu Z, Hruby VJ (2019) Toward a universal mu-agonist template for template-based alignment modeling of opioid ligands. ACS Omega 4:17457–17476

    Article  CAS  Google Scholar 

  • Xing C, Zhuang Y, Xu TH, Feng Z, Zhou XE, Chen M, Wang L, Meng X, Xue Y, Wang J, Liu H, McGuire TF, Zhao G, Melcher K, Zhang C, Xu HE, Xie XQ (2020) Cryo-EM structure of the human cannabinoid receptor CB2-Gi signaling complex. Cell 8674:30054–30054

    Google Scholar 

Download references

Acknowledgements

This paper is dedicated to a special issue of Medicinal Chemistry Research in honoring Professor Hanzlik for his 49 years of teaching and research at the Department of Medicinal Chemistry, University of Kansas.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhijun Wu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, Z., Knapp, S. & Hruby, V. Template-based alignment modeling: an innovative ligand-based approach for medicinal chemists. Med Chem Res 29, 1160–1167 (2020). https://doi.org/10.1007/s00044-020-02562-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-020-02562-z

Keywords

Navigation